Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?
10:45am, Thursday, 05'th Dec 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Here's Why Fresenius (FMS) is a Strong Value Stock
10:45am, Tuesday, 03'rd Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:46am, Thursday, 14'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?
10:45am, Monday, 11'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
12:11pm, Wednesday, 06'th Nov 2024
FMS' third-quarter results showcase a strong segmental performance. The company raises its full-year 2024 outlook for operating income.
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
10:55am, Wednesday, 06'th Nov 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO
08:33pm, Tuesday, 05'th Nov 2024
Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare firm's third-quarter earnings.
Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript
02:34pm, Tuesday, 05'th Nov 2024
Fresenius Medical Care AG (NYSE:FMS ) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer an
Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024
07:00am, Tuesday, 05'th Nov 2024
Organic revenue growth of +2% supported by Care Enablement and Care Delivery Underlying U.S. dialysis treatment volume growth turns positive Exceeding full year FME25 savings target, with additional E
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
10:46am, Tuesday, 22'nd Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
A dedicated session will highlight new advancements in hemodiafiltration therapy showcasing its potential to improve patient outcomes through enhanced toxin removal in dialysis treatments. Company-wi
Here's Why Fresenius (FMS) is a Strong Value Stock
10:45am, Tuesday, 08'th Oct 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fresenius Medical Care: Let's Look At The Upside
04:04pm, Friday, 04'th Oct 2024
Fresenius Medical Care is a BBB-rated leader in kidney care with a 3.1% yield, undervalued at 14x P/E, and poised for growth by 2025-2026E. Despite recent earnings declines, the company expects growth
Here's Why Fresenius (FMS) is a Strong Momentum Stock
10:50am, Friday, 04'th Oct 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FMS Stock Rides on Diversified Portfolio and Restructuring Initiatives
08:11am, Thursday, 03'rd Oct 2024
Fresenius Medical Care's diversified portfolio helps to fight competition and maintain market leadership.
